Status: Recruiting
Early Angiotensin II in the Emergency Department
This pilot study will enroll 20 patients with septic shock and require emergent vasopressor support in the emergency department (ED). The primary objective of the study is to determine the feasibility of early peripheral administration of angiotensin II for treatment of septic shock in the ED
Participants needed: 20
Trial details
Phase: Phase 4Age: 18-99Biological sex: AllType: InterventionalSponsor: Brett A FaineUpdated: Sep 2, 2026Locations: 1
Eligibility criteria
Age ≥18; and [+3]
Acute coronary syndrome; [+7]